ANCA-Associated Vasculitis: Clinical Trials

3 trials for ANCA-Associated Vasculitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Not yet recruiting 1, Recruiting 1
Phase 21Completed 1

Follow ANCA-Associated Vasculitis: new trials by email Literature Review of ANCA-Associated Vasculitis trials Research Report on ANCA-Associated Vasculitis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases
universal allogeneic anti-CD19/BCMA CAR T-cells - Systemic Lupus Erythematosus, Autoimmune Hemolytic Anemia
Phase 1Not yet recruitingChangzhou No.2 People's Hospital182025-05-012025-05-18
The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases
FKC289 - Lupus Nephritis, ANCA-associated Vasculitis
Phase 1RecruitingNanjing University School of Medicine242024-03-042026-07-06
Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis
BDB-001 injection, Cyclophosphamide, Glucocorticoids - ANCA-associated Vasculitis
Phase 1 / Phase 2CompletedStaidson (Beijing) Biopharmaceuticals Co., Ltd932022-02-222025-08-07

Narrower conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (3)  ·  Immunoglobulin G4-Related Disease (2)  ·  Anemia, Hemolytic, Autoimmune (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Lupus Nephritis (1)  ·  Myasthenia Gravis (1)  ·  Myositis (1)  ·  Scleroderma, Systemic (1)

Broader conditions

Autoimmune Diseases (3)  ·  Cardiovascular Diseases (3)  ·  Immune System Diseases (3)  ·  Skin Diseases (3)  ·  Skin Diseases, Vascular (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Systemic Vasculitis (3)  ·  Vascular Diseases (3)  ·  Vasculitis (3)  ·  Connective Tissue Diseases (2)  ·  Anemia (1)  ·  Anemia, Hemolytic (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)

Interventions

BDB001 (1)  ·  Cyclophosphamide (1)  ·  Glucocorticoids (1)  ·  Prednisone (1)

Sponsors

Changzhou No.2 People's Hospital (1)  ·  Nanjing University School of Medicine (1)  ·  Staidson (Beijing) Biopharmaceuticals Co., Ltd (1)

Countries

China (3)

Top investigators

Minghui Zhao, Postdoc (1)  ·  Zhihong Liu (1)